Australia vs Panama: HIV/AIDS deaths averted by antiretroviral therapy
Australia
989.62 deaths
in 2022
Panama
934.45 deaths
in 2024
Australia rank
74th
Panama rank
76th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Australia
- Panama
How they compare
Australia currently reports 989.62 deaths against 934.45 deaths in Panama, a difference of 55.17 deaths.
That makes Australia's figure about 1.1 times Panama's.
The two have swapped places 1 time across 33 shared years of data; in 1990 it was Panama ahead.
Australia ranks 74th and Panama ranks 76th of 157 countries.
Australia has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Australia | Panama | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 260.07 deaths | 8.02 deaths | 252.05 deaths | Australia |
| 2000s | 740.59 deaths | 346.22 deaths | 394.37 deaths | Australia |
| 2010s | 840.56 deaths | 668.17 deaths | 172.39 deaths | Australia |
| 2020s | 982.57 deaths | 666.69 deaths | 315.88 deaths | Australia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Australia or Panama?
- Australia, at 989.62 deaths against 934.45 deaths in Panama as of 2022.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Australia and Panama?
- 55.17 deaths, with Australia ahead.
- How many years of comparable data are there for Australia and Panama?
- 33 years are reported by both, from 1990 to 2022.
- How do Australia and Panama rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Australia ranks 74th and Panama ranks 76th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.